Find similar content

Source channel @githubtrending · Post #14907 · Jul 3

#python#agents#generative_ai_tools#llamacpp#llm#onnx#openvino#parsing#retrieval_augmented_generation#small_specialized_models llmware is a powerful, easy-to-use platform that helps you build AI applications using small, specialized language models designed for business tasks like question-answering, summarization, and data extraction. It supports private, secure deployment on your own machines without needing expensive GPUs, making it cost-effective and safe for enterprise use. You can organize and search your documents, run smart queries, and combine knowledge with AI to get accurate answers quickly. It also offers many ready-to-use models and examples, plus tools for building chatbots and agents that automate complex workflows. This helps you save time, improve accuracy, and securely leverage AI for your business needs[1][3][5]. https://github.com/llmware-ai/llmware

Hashtags

#python #agents #generative_ai_tools #llamacpp #llm #onnx #openvino #parsing #retrieval_augmented_generation #small_specialized_models

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment